Question 1

What is MedAstra?

Accepted Answer

MedAstra is a modern weight-management platform for Indian adults. It combines clinician-guided GLP-1 therapy where appropriate with structured habit systems, appetite tracking and ongoing progress support.

Question 2

What are GLP-1 medications?

Accepted Answer

GLP-1 medications, such as semaglutide and tirzepatide, mimic a natural gut hormone that regulates appetite and fullness. They are used in metabolic and weight-management care under medical supervision.

Question 3

Does MedAstra prescribe medication directly?

Accepted Answer

No. Eligibility, prescription and dosing are decided by qualified clinicians based on your medical history. MedAstra structures the assessment, tracking and ongoing support around that care.

Question 4

Who is GLP-1 therapy suitable for?

Accepted Answer

Typically adults meeting specific BMI and health criteria, after a clinician-led review. GLP-1 medications are not suitable for everyone, including during pregnancy or with certain medical conditions.

Question 5

What kind of weight loss is realistic?

Accepted Answer

Sustainable fat loss is typically in the range of 0.3–0.7 kg per week on average. MedAstra is designed around steady progress, not viral 30-day transformations.

Question 6

Are there side effects?

Accepted Answer

GLP-1 medications can cause side effects, most commonly digestive — nausea, reflux and bowel changes — especially during dose escalation. Your clinician guides dose and timing accordingly.

Question 7

Is my data private?

Accepted Answer

Yes. Health data is encrypted, never sold, and you can export or delete it at any time. Privacy-first design is non-negotiable for us.

Question 8

Is MedAstra only for India?

Accepted Answer

MedAstra is designed primarily for Indian users — local schedules, lifestyles and clinician workflows — and is the experience we optimise for today.

Honest answers about GLP-1 weight management.

Ready to see if GLP-1 support is right for you?